Four Thought Financial Partners, LLC Astrazeneca PLC Transaction History
Four Thought Financial Partners, LLC
- $873 Billion
- Q1 2024
A detailed history of Four Thought Financial Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Four Thought Financial Partners, LLC holds 88,743 shares of AZN stock, worth $6.98 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
88,743
Previous 60,422
46.87%
Holding current value
$6.98 Million
Previous $4.07 Billion
47.74%
% of portfolio
0.69%
Previous 0.51%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,269Shares Held
483MCall Options Held
5.99MPut Options Held
5.22M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.82 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.87 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.38 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.72 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.36 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $244B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...